IL68630A - Preparation of 2-guanidino-4-(2-(substituted amino)-4-imidazolyl)-thiazoles and novel intermediates used therefor - Google Patents

Preparation of 2-guanidino-4-(2-(substituted amino)-4-imidazolyl)-thiazoles and novel intermediates used therefor

Info

Publication number
IL68630A
IL68630A IL68630A IL6863083A IL68630A IL 68630 A IL68630 A IL 68630A IL 68630 A IL68630 A IL 68630A IL 6863083 A IL6863083 A IL 6863083A IL 68630 A IL68630 A IL 68630A
Authority
IL
Israel
Prior art keywords
thiazoles
guanidino
imidazolyl
preparation
substituted amino
Prior art date
Application number
IL68630A
Other languages
English (en)
Other versions
IL68630A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL68630A0 publication Critical patent/IL68630A0/xx
Priority to IL79569A priority Critical patent/IL79569A0/xx
Publication of IL68630A publication Critical patent/IL68630A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Lubricants (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
IL68630A 1982-05-10 1983-05-09 Preparation of 2-guanidino-4-(2-(substituted amino)-4-imidazolyl)-thiazoles and novel intermediates used therefor IL68630A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL79569A IL79569A0 (en) 1982-05-10 1986-07-30 Antiulcer 2-guanidino-4-(2-(substituted amino)-4-imidazolyl)thiazoles and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/376,486 US4435396A (en) 1982-05-10 1982-05-10 Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor

Publications (2)

Publication Number Publication Date
IL68630A0 IL68630A0 (en) 1983-09-30
IL68630A true IL68630A (en) 1987-03-31

Family

ID=23485203

Family Applications (1)

Application Number Title Priority Date Filing Date
IL68630A IL68630A (en) 1982-05-10 1983-05-09 Preparation of 2-guanidino-4-(2-(substituted amino)-4-imidazolyl)-thiazoles and novel intermediates used therefor

Country Status (26)

Country Link
US (1) US4435396A (de)
EP (1) EP0094191B1 (de)
JP (1) JPS58206588A (de)
KR (1) KR860000931B1 (de)
AT (1) ATE33649T1 (de)
AU (2) AU539244B2 (de)
CA (1) CA1201120A (de)
CS (1) CS252461B2 (de)
DD (1) DD209828A5 (de)
DE (1) DE3376322D1 (de)
DK (1) DK163829B (de)
EG (1) EG17029A (de)
ES (1) ES8407045A1 (de)
FI (1) FI78481C (de)
GR (1) GR79279B (de)
GT (1) GT198302123A (de)
HU (2) HU196377B (de)
IE (1) IE55229B1 (de)
IL (1) IL68630A (de)
NO (1) NO159932C (de)
NZ (1) NZ204158A (de)
PL (1) PL141199B1 (de)
PT (1) PT76662B (de)
SU (1) SU1195907A3 (de)
YU (1) YU42857B (de)
ZA (1) ZA833286B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
US4636498A (en) * 1984-10-11 1987-01-13 Pfizer Inc. Formulation of antiinflammatory drugs
US4632993A (en) * 1984-10-11 1986-12-30 Pfizer Inc. Process for making 2-guanidino-4-(2-methyl-4-imidazolyl) thiazole dihydrobromide
WO1986003203A1 (en) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Thienylthiazole derivatives
US4814341A (en) * 1986-08-26 1989-03-21 Reiter Lawrence A 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents
EP0259085B1 (de) * 1986-08-29 1991-08-21 Pfizer Inc. 2-Guanidino-4-aryl-thiazole für die Behandlung von peptischen Geschwüren
EP0269239B1 (de) * 1986-10-29 1994-06-08 Pfizer Inc. Verfahren zur Herstellung von 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)Thiazol und dessen kristallinisches Dihydrochlorid-Trihydrat
CA2165344A1 (en) * 1993-06-15 1994-12-22 Peter C. Canning Immune stimulants in bacterial infections
PE20110843A1 (es) 2008-09-22 2011-12-08 Cayman Chem Co Derivados de 5-(1h-imidazol-5-il)-2-fenilpirimidina, como inhibidores de prostaglandina d sintasa hematopoyetica
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519637A (en) 1966-12-06 1970-07-07 Hoffmann La Roche 1-(4-thiazolylmethyl)nitroimidazole derivatives
DE2142585A1 (de) * 1971-08-20 1973-02-22 Schering Ag 2-(5-nitro-2-thiazolyl)-benzimidazole
FR2284601A1 (fr) * 1974-09-10 1976-04-09 Inst Francais Du Petrole Composes guanidino-heterocycliques alkyles, leur preparation et leur utilisation comme additifs pour carburants et lubrifiants
US4220654A (en) 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
US4374843A (en) * 1980-10-14 1983-02-22 Pfizer Inc. 2-Guanidino-4-heteroarylthiazoles

Also Published As

Publication number Publication date
PT76662B (en) 1986-04-16
EP0094191B1 (de) 1988-04-20
IL68630A0 (en) 1983-09-30
NO159932B (no) 1988-11-14
FI78481B (fi) 1989-04-28
DD209828A5 (de) 1984-05-23
DK163829B (da) 1992-04-06
SU1195907A3 (ru) 1985-11-30
EG17029A (en) 1992-06-30
GR79279B (de) 1984-10-22
PL141199B1 (en) 1987-07-31
FI78481C (fi) 1989-08-10
NZ204158A (en) 1986-05-09
ES522223A0 (es) 1984-08-16
ATE33649T1 (de) 1988-05-15
PT76662A (en) 1983-06-01
DE3376322D1 (en) 1988-05-26
HU196377B (en) 1988-11-28
HU190899B (en) 1986-12-28
KR860000931B1 (ko) 1986-07-19
FI831595A0 (fi) 1983-05-09
PL241840A1 (en) 1985-01-16
YU99683A (en) 1986-02-28
AU3081584A (en) 1984-11-08
GT198302123A (es) 1984-10-27
CS318483A2 (en) 1987-02-12
DK205883A (da) 1983-11-11
ES8407045A1 (es) 1984-08-16
FI831595L (fi) 1983-11-11
ZA833286B (en) 1984-12-24
NO159932C (no) 1989-02-22
AU539244B2 (en) 1984-09-20
CA1201120A (en) 1986-02-25
DK205883D0 (da) 1983-05-09
IE831061L (en) 1983-11-10
NO831632L (no) 1983-11-11
EP0094191A1 (de) 1983-11-16
JPS58206588A (ja) 1983-12-01
US4435396A (en) 1984-03-06
IE55229B1 (en) 1990-07-04
AU566755B2 (en) 1987-10-29
KR840004745A (ko) 1984-10-24
AU1436383A (en) 1983-11-17
YU42857B (en) 1988-12-31
CS252461B2 (en) 1987-09-17

Similar Documents

Publication Publication Date Title
PT73259B (en) Process for preparing novel substituted pyrazinyl-1,2,4-oxadiazole-5-ones
YU88283A (en) Process for obtaining hypoglycemic 5-substituted oxazolidine 2,4-diones
YU43977B (en) Process for obtaining new 2-(n-substituted-guanidine)-4-heteroarylthiazole
IL68630A (en) Preparation of 2-guanidino-4-(2-(substituted amino)-4-imidazolyl)-thiazoles and novel intermediates used therefor
BG42004A3 (en) Method for preparing pyridyl compounds
PT73436B (en) Process for preparing hypoglycemic 5-substituted oxazolidine- -2,4-diones
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
IT8621384A0 (it) Metodo per il trattamento di lenti a contatto.
IT8019122A0 (it) Metodo e composizione per il trattamento di lenti a contatto.
YU43601B (en) Process for preparation of 2-(2-fluoro-4-trifluoro-methyl-phenyl) 1,3 di(1,2,4-triazole-1-ile)-2-propanol
DE3166322D1 (en) Process for the preparation of 2-(2,2,2,-trichloro-1-hydroxy-ethyl) phenols
RO84659B (ro) Procedeu pentru purificarea r-(bis-(2-cloretil)amino)-tetrahido-2h, 1, 5, 2-oxazofosforian-2-oxidului monohidratat
IL59382A0 (en) A new process for the preparation of fluorinated amino acids,hydroxy amino acids,fluoro-hydroxy-amino acids and novel compounds obtained